Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease

Ward MG, Thwaites PA, Beswick L, Hogg J, Rosella G, Van Langenberg D, Reynolds J, Gibson PR, Sparrow MP

(2017), Aliment Pharmacol Ther, 45(8), 1135-45

DOI: 10.1111/apt.13992

Endometriosis in patients with irritable bowel syndrome: specific symptomatic and demographic profile, and response to the low FODMAP diet

Moore JS, Gibson PR, Perry RE, Burgell RE

(2017), Aust N Z J Obstet Gynaecol, 57(2), 201-5

DOI: 10.1111/ajo.12594

Challenges of Quantifying FODMAPs in Enteral Nutrition Formulas: Evaluation of Artifacts and Solutions

Halmos EP, Bogatyrev A, Ly E, Liels KL, Muir JG, Gibson PR

(2017), J Parenter Enteral Nutr, 41(8), 1262-71

DOI: 10.1177/0148607116658763

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

Ward MG, Warner B, Unsworth N, Chuah SW, Brownclarke C, Shieh S, Parkes M, Sanderson JD, Arkir Z, Reynolds J, Gibson PR, Irving PM

(2017), Aliment Pharmacol Ther, 46(2), 150-61

DOI: 10.1111/apt.14124

A prospective comparison of cold snare polypectomy using traditional or dedicated cold snares for the resection of small sessile colorectal polyps

Dwyer JP, Tan JYC, Urquhart P, Secomb R, Bunn C, Reynolds J, La Nauze R, Kemp W, Roberts S, Brown G

(2017), Endosc Int Open, 5(11), E1062-8

DOI: 10.1055/s-0043-113564

FODMAPs: food composition, defining cutoff values and international application

Varney J, Barrett J, Scarlata K, Catsos P, Gibson PR, Muir JG

(2017), J Gastroenterol Hepatol, 32 (Suppl 1), 53-61

DOI: 10.1111/jgh.13698

Non-coeliac gluten sensitivity

Gibson PR, Skodje GI, Lundin KE

(2017), J Gastroenterol Hepatol, 32 (Suppl 1), 86-9

DOI: 10.1111/jgh.13705

The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?

Gibson PR

(2017), J Gastroenterol Hepatol, 32 (Suppl 1), 32-35

DOI: 10.1111/jgh.13693

Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population

Eales J, Gibson P, Whorwell P, Kellow J, Yellowlees A, Perry RH, Edwards M, King S, Wood H, Glanville J

(2017), Ther Adv Gastroenterol, 10(1), 74-88

DOI: 10.1177/1756283X16670075

Complementary and Alternative Medicines Used by Patients WithÜInflammatory Bowel Diseases

Cheifetz AS, Gianotti R, Luber R, Gibson PR

(2017), Gastroenterology, 152(2), 415-29.e15

DOI: 10.1053/j.gastro.2016.10.004

Carbohydrate and protein intake during exertional-heat stress ameliorates intestinal epithelial injury and small intestine permeability.

Snipe RMJ, Khoo A, Kitic CM, Gibson PR, Costa RJS

(2017), Appl Physiol Nutr Metab, 42(12), 1283-92

DOI: 10.1139/apnm-2017-0361

Systematic review: exercise-induced gastrointestinal syndrome-implications for health and intestinal disease

Costa RJS, Snipe RMJ, Kitic CM, Gibson PR

(2017), Aliment Pharmacol Ther, 46(3), 246-265

DOI: 10.1111/apt.14157

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases

Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, Barclay M, Begun J, Bryant R, Chan W, Corte C, Ghaly S, Lemberg DA, Kariyawasam V, Lewindon P, Martin J, Mountifield R, Radford-Smith G, Slobodian P, Sparrow M, Toong C, van Langenberg D, Ward MG, Leong RW; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group

(2017), Aliment Pharmacol Ther, 46(11-12), 1037-53

DOI: 10.1111/apt.14368

Controversies and recent developments of the low-FODMAP diet

Hill P, Muir JG, Gibson PR

(2017), Gastroenterology Hepatology, 13(1), 36-45

Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes

Christensen B, Hanauer SB, Erlich J, Kassim O, Gibson PR, Turner JR, Hart J, Rubin DT

(2017), Clin Gastroenterol Hepatol, 15(10), 1557-1564.e1

DOI: 10.1016/j.cgh.2017.02.016

Serologic antibodies in relation to outcome in postoperative Crohn's disease

Hamilton AL, Kamm MA, De Cruz P, Wright EK, Selvaraj F, Princen F, Gorelik A, Liew D, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Bell SJ, Brown SJ, Connell WR

(2017), J Gastroenterol Hepatol, 32(6), 1195-1203

DOI: 10.1111/jgh.13677

Cognitive impairment in CrohnÌs disease is associated with systemic inflammation, symptom burden and sleep disturbance

van Langenberg DR, Yelland GW, Robinson SR, Gibson PR

(2017), United European Gastroenterol J, 5(4), 579-87

DOI: 10.1177/2050640616663397

Poor reproducibility of breath hydrogen testing: implications for its application in functional bowel disorders

Yao CK, Tuck CJ, Barrett JS, Canale KE, Philpott HL, Gibson PR

(2017), United European Gastroenterol J, 5(2), 284-92

DOI: 10.1177/2050640616657978

Naturally occurring dietary salicylates: a closer look at common Australian foods

Malakar S, Gibson PR, Barrett JS, Muir JG

(2017), J Food Compos Anal, 57, 31-9

DOI: 10.1016/j.jfca.2016.12.008

Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: a meta-analysis

Wedemeyer H, Craxà A, Zuckerman E, Dieterich D, Flisiak R, Roberts SK, Pangerl A, Zhang Z, Martinez M, Bao Y, Calleja JL

(2017), J Viral Hepat, 24(11), 936-43

DOI: 10.1111/jvh.12722

305 306 307 308 309